top of page

OUR FUNDS

Institutionally Designed Funds Built for Performance & Capital Protection

A diversified mix of alternative strategies engineered to deliver asymmetric upside with controlled, verifiable risk—designed for physicians and accredited investors.

Request Offering Documents

Active Funds

Open for allocation to qualified investors

TECHNOLOGY

Eagle Pre-IPO Fund

HIGHLIGHTS

  • Access to late-stage AI, cybersecurity, digital payments, and enterprise SaaS

​

  • Avg entry valuation 41–63% below expected IPO ranges

​

  • Sector multiples: 3.2× historical exits

Status: Open for Allocation

RESIDENTIAL REAL ESTATE

Build-to-Rent Real Estate Fund

HIGHLIGHTS

  • Markets: Dallas, Austin, Phoenix

  • Avg occupancy: 94%

  • Rent growth: 6–9% YoY

  • IRR Range: 18–24%

Status: Open for Allocation

TECHNOLOGY

Specialty Credit Fund

HIGHLIGHTS

  • Avg yield: 12–18%

​

  • Loan-to-value: <50%

​

  • 100% collateralized

​

  • Zero default history

Status: Open for Allocation

Closed Funds

Institutional transparency on historical performance

BioWise Medtech Fund

  • Portfolio Companies

  • 16

​

  • Successful Exits

  • 3

​​

  • FDA Trials

  • 2 in pivotal-stage

​

  • Historical IRR

  • 22.4%

​​

  • Loss Ratio

  • 0%

Smart Block Capital Fund

  • Total Returns

  • 2.0× (5-year hold)

​

  • Exposure

  • Digital asset

​

  • Exit Status

  • Successfully exited 2024

​

  • Investor Status

  • Closed to new investors

Private Credit Fund 2022

  • Status

  • Fully repaid

​

  • Default Rate

  • Zero defaults

​

  • Timeline

  • 18-month window

​​​

  • Distributions

  • 100% on-time

Fund Comparison

Structured for institutional clarity and informed decision-making

Untitled design (15).png

FUND

TARGET RETURN

RISK LEVEL

LOCKUP / TERM

DISTRIBUTION

ASSET TYPE

INVESTOR FIT

Eagle Pre-IPO Fund

Build-to-Rent Real Estate

Specialty Credit Fund

18–24% IRR

Medium

5–7 years

Quarterly cash flow

Residential real estate

Income + appreciation seekers

3.0–5.0× multiple

Medium-High

4–7 years

Upon exit events

Late-stage equity

High risk tolerance, long horizon

12–18% yield

Low-Medium

18–36 months

Monthly or quarterly

Secured private credit

Conservative income focus

Why Baluch Funds Outperform

Institutional-grade frameworks built for sophisticated investors

7.png
Asymmetric Upside

Access to sectors unavailable to public markets.

9.png
Controlled Downside

Collateral, senior liens, conservative valuations.

7.png
Non-Correlation to Public Markets

Reduced volatility and smoother return profiles.

Capital Flow Trust Signals

The strongest proof of performance is investor behavior

72%

reinvestment rate

Limited partners who reinvest across multiple funds

41%

YoY increase in physician LPs

Growing trust from medical professionals

428

distributions paid to date

Consistent execution and investor returns

0

delays, 0 losses

Perfect track record of capital stewardship

READY TO INVEST

6.png
6.png

Access Institutional-Grade Alternative Investing

Schedule a confidential consultation to discuss fund allocation strategies designed for your portfolio.

View Investment Thesis

bottom of page